Choice of designs and doses for early phase trials

Full text not archived in this repository.

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Zhou, Y. (2004) Choice of designs and doses for early phase trials. Fundamental & Clinical Pharmacology, 18 (3). pp. 373-378. ISSN 0767-3981 doi: 10.1111/j.1472-8206.2004.00226.x

Abstract/Summary

This paper reviews state-of-art statistical designs for dose-escalation procedures in first-into-man studies. The main focus will be on studies in oncology, as most statistical procedures for phase I trials have been proposed in this context. Extensions to situations such as the observation of bivariate outcomes and healthy volunteer studies are also discussed. The number of dose levels and cohort sizes used in early phase trials are considered. Finally, this paper raises some practical issues for dose-escalation procedures.

Altmetric Badge

Item Type Article
URI https://reading-clone.eprints-hosting.org/id/eprint/9430
Identification Number/DOI 10.1111/j.1472-8206.2004.00226.x
Refereed Yes
Divisions Science > School of Mathematical, Physical and Computational Sciences > Department of Mathematics and Statistics > Applied Statistics
Uncontrolled Keywords dose-escalation , first-into-man , statistical designs
Download/View statistics View download statistics for this item

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar